
Justin Zelin
Stock Analyst at BTIG
(2.85)
# 2,739
Out of 5,189 analysts
344
Total ratings
34.1%
Success rate
1.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterated: Buy | $9 | $6.02 | +49.50% | 6 | Feb 2, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $100 | $10.08 | +892.06% | 8 | Jan 22, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $0.83 | +984.34% | 5 | Jan 6, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $45 | $10.52 | +327.76% | 2 | Jan 2, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $56 | $8.72 | +542.20% | 26 | Jan 2, 2026 | |
| KURA Kura Oncology | Reiterated: Hold | n/a | $6.91 | - | 20 | Dec 9, 2025 | |
| TCRX TScan Therapeutics | Reiterated: Hold | n/a | $0.1459 | - | 10 | Dec 9, 2025 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $50 | $11.97 | +317.71% | 2 | Dec 2, 2025 | |
| JSPR Jasper Therapeutics | Reiterated: Buy | $210 | $8.69 | +2,316.57% | 14 | Dec 2, 2025 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $62 | $25.56 | n/a | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.33 | n/a | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $24.77 | n/a | 36 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.8634 | n/a | 2 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $46.53 | n/a | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $15.25 | n/a | 38 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $26.41 | n/a | 13 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0002 | n/a | 5 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.14 | n/a | 21 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.04 | n/a | 10 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $7.40 | n/a | 15 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.3541 | n/a | 22 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.62 | n/a | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.10994 | n/a | 8 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8026 | n/a | 14 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.2201 | n/a | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $3 | $2.42 | n/a | 4 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.8707 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $308.89 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0002 | n/a | 3 | Nov 11, 2020 |
ImmunityBio
Feb 2, 2026
Reiterated: Buy
Price Target: $9
Current: $6.02
Upside: +49.50%
Janux Therapeutics
Jan 22, 2026
Reiterated: Buy
Price Target: $100
Current: $10.08
Upside: +892.06%
NovaBridge Biosciences
Jan 6, 2026
Reiterated: Buy
Price Target: $9
Current: $0.83
Upside: +984.34%
ArriVent BioPharma
Jan 2, 2026
Reiterated: Buy
Price Target: $45
Current: $10.52
Upside: +327.76%
Syndax Pharmaceuticals
Jan 2, 2026
Reiterated: Buy
Price Target: $56
Current: $8.72
Upside: +542.20%
Kura Oncology
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $6.91
Upside: -
TScan Therapeutics
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.1459
Upside: -
Ascentage Pharma Group International
Dec 2, 2025
Reiterated: Buy
Price Target: $50
Current: $11.97
Upside: +317.71%
Jasper Therapeutics
Dec 2, 2025
Reiterated: Buy
Price Target: $210
Current: $8.69
Upside: +2,316.57%
IDEAYA Biosciences
Nov 4, 2025
Reiterated: Buy
Price Target: $62
Current: $25.56
Upside: n/a
Nov 4, 2025
Reiterated: Buy
Price Target: $20
Current: $6.33
Upside: n/a
Oct 30, 2025
Reiterated: Buy
Price Target: $125
Current: $24.77
Upside: n/a
Sep 17, 2025
Reiterated: Buy
Price Target: $8
Current: $0.8634
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $45
Current: $46.53
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: $91
Current: $15.25
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $91
Current: $26.41
Upside: n/a
Jan 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Sep 10, 2024
Reiterated: Buy
Price Target: $6
Current: $2.14
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $5
Current: $1.04
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $30
Current: $7.40
Upside: n/a
Mar 12, 2024
Reiterated: Buy
Price Target: $8
Current: $0.3541
Upside: n/a
Jul 6, 2023
Rated: Hold
Price Target: n/a
Current: $1.62
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.10994
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.8026
Upside: n/a
Dec 4, 2020
Initiated Coverage: Buy
Price Target: $4
Current: $0.2201
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $2 → $3
Current: $2.42
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $4
Current: $0.8707
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $100
Current: $308.89
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $28
Current: $0.0002
Upside: n/a